International Stem Cell Corp. (ISCO) Provides Details on Public Offering
International Stem Cell Corp., a biotech company developing stem cell based therapies, today announced the pricing of a public offering. Consisting of one share of common stock and one Series A Warrant to purchase one share of our common stock at an exercise price of $0.15 per share, each of the 20,000,000 units are being sold at $0.15. The company is also offering up to 20,000,000 Series B Warrants, each to purchase one unit. Purchasers will receive one Series B Warrant for each unit purchased. Additional details on the Series B Warrants can be found in today’s press release. Each…